Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noscapine in Buerger's disease
IRCT20180103038199N5Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of noscapine in Buerger disease (TAO), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Change in pain visual analog scale. Started Jun 2021; status: completed.
02
Drugs
noscapine
03
Conditions
Buerger disease (TAO)
Beyond the preview
Go deeper on IRCT20180103038199N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180103038199N5.